LPGOLipigon Pharmaceuticals AB
Data unavailable0.0015SEK-44.44%Mkt Cap: 86938 $P/E: —98d ago
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap86.94K $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price0.0015 SEK
Fiscal Year End—
MR Quarter—
Employees—
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0015382072
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
0.00110% of range0.1935
52W High0.1935 SEK
52W Low0.0011 SEK
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)24.47M
Avg Vol (10d)—
Technical Indicators
RSI (14)34.6
MACD-0.0008
MACD Signal-0.0008
MACD Hist.+0.0000
BB Upper0.0045 SEK
BB Middle0.0030 SEK
BB Lower0.0015 SEK
BB Width100.48%
ATR (14)0.0013 SEK
Vol Ratio (20d)5.68x